| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |